Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 84

1.

Differential signaling pathways are initiated in macrophages during infection depending on the intracellular fate of Chlamydia spp.

Nagarajan UM, Tripathy M, Kollipara A, Allen J 4th, Goodwin A, Whittimore J, Wyrick PB, Rank RG.

Immunol Cell Biol. 2018 Mar;96(3):246-256. doi: 10.1111/imcb.1033. Epub 2018 Jan 6.

PMID:
29363185
2.

Progesterone antagonizes the positive influence of estrogen on Chlamydia trachomatis serovar E in an Ishikawa/SHT-290 co-culture model.

Kintner J, Schoborg RV, Wyrick PB, Hall JV.

Pathog Dis. 2015 Jun;73(4). pii: ftv015. doi: 10.1093/femspd/ftv015. Epub 2015 Feb 26.

3.

The DNA sensor, cyclic GMP-AMP synthase, is essential for induction of IFN-β during Chlamydia trachomatis infection.

Zhang Y, Yeruva L, Marinov A, Prantner D, Wyrick PB, Lupashin V, Nagarajan UM.

J Immunol. 2014 Sep 1;193(5):2394-404. doi: 10.4049/jimmunol.1302718. Epub 2014 Jul 28.

4.

The multifaceted role of oestrogen in enhancing Chlamydia trachomatis infection in polarized human endometrial epithelial cells.

Hall JV, Schell M, Dessus-Babus S, Moore CG, Whittimore JD, Sal M, Dill BD, Wyrick PB.

Cell Microbiol. 2011 Aug;13(8):1183-99. doi: 10.1111/j.1462-5822.2011.01608.x. Epub 2011 May 25.

PMID:
21615662
5.

In vivo ultrastructural analysis of the intimate relationship between polymorphonuclear leukocytes and the chlamydial developmental cycle.

Rank RG, Whittimore J, Bowlin AK, Wyrick PB.

Infect Immun. 2011 Aug;79(8):3291-301. doi: 10.1128/IAI.00200-11. Epub 2011 May 16.

6.

Chlamydia trachomatis persistence in vitro: an overview.

Wyrick PB.

J Infect Dis. 2010 Jun 15;201 Suppl 2:S88-95. doi: 10.1086/652394.

7.

Host chemokine and cytokine response in the endocervix within the first developmental cycle of Chlamydia muridarum.

Rank RG, Lacy HM, Goodwin A, Sikes J, Whittimore J, Wyrick PB, Nagarajan UM.

Infect Immun. 2010 Jan;78(1):536-44. doi: 10.1128/IAI.00772-09. Epub 2009 Oct 19.

8.

Trafficking of chlamydial antigens to the endoplasmic reticulum of infected epithelial cells.

Giles DK, Wyrick PB.

Microbes Infect. 2008 Nov-Dec;10(14-15):1494-503. doi: 10.1016/j.micinf.2008.09.001. Epub 2008 Sep 12.

9.

Chlamydiae and polymorphonuclear leukocytes: unlikely allies in the spread of chlamydial infection.

Rank RG, Whittimore J, Bowlin AK, Dessus-Babus S, Wyrick PB.

FEMS Immunol Med Microbiol. 2008 Oct;54(1):104-13. doi: 10.1111/j.1574-695X.2008.00459.x. Epub 2008 Jul 24.

10.

Comparison of Chlamydia trachomatis serovar L2 growth in polarized genital epithelial cells grown in three-dimensional culture with non-polarized cells.

Dessus-Babus S, Moore CG, Whittimore JD, Wyrick PB.

Microbes Infect. 2008 Apr;10(5):563-70. doi: 10.1016/j.micinf.2008.02.002. Epub 2008 Feb 21.

11.

Bioinformatic and biochemical evidence for the identification of the type III secretion system needle protein of Chlamydia trachomatis.

Betts HJ, Twiggs LE, Sal MS, Wyrick PB, Fields KA.

J Bacteriol. 2008 Mar;190(5):1680-90. doi: 10.1128/JB.01671-07. Epub 2007 Dec 28.

12.

Differences in Chlamydia trachomatis serovar E growth rate in polarized endometrial and endocervical epithelial cells grown in three-dimensional culture.

Guseva NV, Dessus-Babus S, Moore CG, Whittimore JD, Wyrick PB.

Infect Immun. 2007 Feb;75(2):553-64. Epub 2006 Nov 6.

13.

The lipid A 1-phosphatase of Helicobacter pylori is required for resistance to the antimicrobial peptide polymyxin.

Tran AX, Whittimore JD, Wyrick PB, McGrath SC, Cotter RJ, Trent MS.

J Bacteriol. 2006 Jun;188(12):4531-41.

14.

Ultrastructural analysis of chlamydial antigen-containing vesicles everting from the Chlamydia trachomatis inclusion.

Giles DK, Whittimore JD, LaRue RW, Raulston JE, Wyrick PB.

Microbes Infect. 2006 May;8(6):1579-91. Epub 2006 Apr 18.

PMID:
16698305
15.

Chlamydia trachomatis enters a viable but non-cultivable (persistent) state within herpes simplex virus type 2 (HSV-2) co-infected host cells.

Deka S, Vanover J, Dessus-Babus S, Whittimore J, Howett MK, Wyrick PB, Schoborg RV.

Cell Microbiol. 2006 Jan;8(1):149-62.

PMID:
16367874
16.

Characterization of estrogen-responsive epithelial cell lines and their infectivity by genital Chlamydia trachomatis.

Guseva NV, Dessus-Babus SC, Whittimore JD, Moore CG, Wyrick PB.

Microbes Infect. 2005 Dec;7(15):1469-81. Epub 2005 Jun 22.

PMID:
16046168
17.
18.

Nuclear factor-kappaB activation in endothelium by Chlamydia pneumoniae without active infection.

Baer JT, Du Laney TV, Wyrick PB, McCain AS, Fischer TA, Merricks EP, Baldwin AS, Nichols TC.

J Infect Dis. 2003 Oct 15;188(8):1094-7. Epub 2003 Oct 1.

PMID:
14551877
19.
21.
22.

Lactobacillus plantarum 299V in the treatment and prevention of spontaneous colitis in interleukin-10-deficient mice.

Schultz M, Veltkamp C, Dieleman LA, Grenther WB, Wyrick PB, Tonkonogy SL, Sartor RB.

Inflamm Bowel Dis. 2002 Mar;8(2):71-80.

PMID:
11854603
23.
24.

Hsp70s contain a specific sulfogalactolipid binding site. Differential aglycone influence on sulfogalactosyl ceramide binding by recombinant prokaryotic and eukaryotic hsp70 family members.

Mamelak D, Mylvaganam M, Whetstone H, Hartmann E, Lennarz W, Wyrick PB, Raulston J, Han H, Hoffman P, Lingwood CA.

Biochemistry. 2001 Mar 27;40(12):3572-82.

PMID:
11297423
25.

Radical changes to chlamydial taxonomy are not necessary just yet.

Schachter J, Stephens RS, Timms P, Kuo C, Bavoil PM, Birkelund S, Boman J, Caldwell H, Campbell LA, Chernesky M, Christiansen G, Clarke IN, Gaydos C, Grayston JT, Hackstadt T, Hsia R, Kaltenboeck B, Leinonnen M, Ojcius D, McClarty G, Orfila J, Peeling R, Puolakkainen M, Quinn TC, Rank RG, Raulston J, Ridgeway GL, Saikku P, Stamm WE, Taylor-Robinson DT, Wang SP, Wyrick PB.

Int J Syst Evol Microbiol. 2001 Jan;51(Pt 1):249; author reply 251-3. No abstract available. Erratum in: Int J Syst Evol Microbiol. 2006 Mar;56(Pt 3):677. Ocjius, D [corrected to Ojcius, D].

PMID:
11211265
26.
27.

Intracellular survival by Chlamydia.

Wyrick PB.

Cell Microbiol. 2000 Aug;2(4):275-82. Review.

PMID:
11207584
28.

Persistent chlamydial envelope antigens in antibiotic-exposed infected cells trigger neutrophil chemotaxis.

Wyrick PB, Knight ST, Paul TR, Rank RG, Barbier CS.

J Infect Dis. 1999 Apr;179(4):954-66.

PMID:
10068592
30.

Chlamydial elementary bodies are translocated on the surface of epithelial cells.

Campbell S, Larsen J, Knight ST, Glicksman NR, Wyrick PB.

Am J Pathol. 1998 May;152(5):1167-70.

31.
33.

The microbicidal agent C31G inhibits Chlamydia trachomatis infectivity in vitro.

Wyrick PB, Knight ST, Gerbig DG Jr, Raulston JE, Davis CH, Paul TR, Malamud D.

Antimicrob Agents Chemother. 1997 Jun;41(6):1335-44.

34.

Delivery of azithromycin to Chlamydia trachomatis-infected polarized human endometrial epithelial cells by polymorphonuclear leucocytes.

Paul TR, Knight ST, Raulston JE, Wyrick PB.

J Antimicrob Chemother. 1997 May;39(5):623-30.

PMID:
9184362
35.

The late chlamydial inclusion membrane is not derived from the endocytic pathway and is relatively deficient in host proteins.

Taraska T, Ward DM, Ajioka RS, Wyrick PB, Davis-Kaplan SR, Davis CH, Kaplan J.

Infect Immun. 1996 Sep;64(9):3713-27.

36.

Vesicles containing Chlamydia trachomatis serovar L2 remain above pH 6 within HEC-1B cells.

Schramm N, Bagnell CR, Wyrick PB.

Infect Immun. 1996 Apr;64(4):1208-14.

37.

Transferrin increases adherence of iron-deprived Neisseria gonorrhoeae to human endometrial cells.

Heine RP, Elkins C, Wyrick PB, Sparling PF.

Am J Obstet Gynecol. 1996 Feb;174(2):659-66.

PMID:
8623803
38.

Accelerated development of genital Chlamydia trachomatis serovar E in McCoy cells grown on microcarrier beads.

Wyrick PB, Gerbig DG Jr, Knight ST, Raulston JE.

Microb Pathog. 1996 Jan;20(1):31-40.

PMID:
8692008
39.

Characterization, expression and envelope association of a Chlamydia trachomatis 28 kDa protein.

Schmiel DH, Raulston JE, Fox E, Wyrick PB.

Microb Pathog. 1995 Oct;19(4):227-36.

PMID:
8825910
40.

Cytoskeletal requirements in Chlamydia trachomatis infection of host cells.

Schramm N, Wyrick PB.

Infect Immun. 1995 Jan;63(1):324-32.

41.

Effect of clinically relevant culture conditions on antimicrobial susceptibility of Chlamydia trachomatis.

Wyrick PB, Davis CH, Raulston JE, Knight ST, Choong J.

Clin Infect Dis. 1994 Nov;19(5):931-6. Review.

PMID:
7893882
42.
43.

An in vitro model for immune control of chlamydial growth in polarized epithelial cells.

Igietseme JU, Wyrick PB, Goyeau D, Rank RG.

Infect Immun. 1994 Aug;62(8):3528-35.

45.

Expression of recombinant DNA introduced into Chlamydia trachomatis by electroporation.

Tam JE, Davis CH, Wyrick PB.

Can J Microbiol. 1994 Jul;40(7):583-91.

PMID:
8076253
46.

Vaccines for bacterial sexually transmitted infections: a realistic goal?

Sparling PF, Elkins C, Wyrick PB, Cohen MS.

Proc Natl Acad Sci U S A. 1994 Mar 29;91(7):2456-63. Review.

47.

Culture and isolation of Chlamydia trachomatis.

Schachter J, Wyrick PB.

Methods Enzymol. 1994;236:377-90. No abstract available.

PMID:
7968623
48.

Molecular characterization and outer membrane association of a Chlamydia trachomatis protein related to the hsp70 family of proteins.

Raulston JE, Davis CH, Schmiel DH, Morgan MW, Wyrick PB.

J Biol Chem. 1993 Nov 5;268(31):23139-47. Erratum in: J Biol Chem 1994 Apr 1;269(13):10184.

49.

An in vitro human epithelial cell culture system for studying the pathogenesis of Chlamydia trachomatis.

Wyrick PB, Davis CH, Knight ST, Choong J, Raulston JE, Schramm N.

Sex Transm Dis. 1993 Sep-Oct;20(5):248-56. No abstract available.

PMID:
8235920
50.

In-vitro activity of azithromycin on Chlamydia trachomatis infected, polarized human endometrial epithelial cells.

Wyrick PB, Davis CH, Knight ST, Choong J.

J Antimicrob Chemother. 1993 Jan;31(1):139-50.

PMID:
8383102

Supplemental Content

Loading ...
Support Center